more attention focused on urinary incontinence
August 2001
You'll see more attention focused on urinary incontinence.
This is a big problem. More than 15 million people in North America suffer from bladder problems...only about 10% seek help.
The attention is partly fueled by interest in new extended-release versions of Ditropan (oxybutynin) and Detrol (tolterodine).
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive